Package 67046-1622-3

Brand: terazosin

Generic: terazosin hydrochloride
NDC Package

Package Facts

Identity

Package NDC 67046-1622-3
Digits Only 6704616223
Product NDC 67046-1622
Description

30 CAPSULE in 1 BLISTER PACK (67046-1622-3)

Marketing

Marketing Status
Marketed Since 2025-12-16
Brand terazosin
Generic terazosin hydrochloride
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "4614e8cc-c8ea-4c0f-e063-6394a90a8501", "openfda": {"unii": ["D32S14F082"], "rxcui": ["313219"], "spl_set_id": ["4614e8cc-c922-4c0f-e063-6394a90a8501"], "manufacturer_name": ["Coupler LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BLISTER PACK (67046-1622-3)", "package_ndc": "67046-1622-3", "marketing_start_date": "20251216"}], "brand_name": "Terazosin", "product_id": "67046-1622_4614e8cc-c8ea-4c0f-e063-6394a90a8501", "dosage_form": "CAPSULE", "pharm_class": ["Adrenergic alpha-Antagonists [MoA]", "alpha-Adrenergic Blocker [EPC]"], "product_ndc": "67046-1622", "generic_name": "Terazosin Hydrochloride", "labeler_name": "Coupler LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Terazosin", "active_ingredients": [{"name": "TERAZOSIN HYDROCHLORIDE", "strength": "5 mg/1"}], "application_number": "ANDA075317", "marketing_category": "ANDA", "marketing_start_date": "20251216", "listing_expiration_date": "20261231"}